1420 related items for PubMed ID: 16898486
1. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[Abstract] [Full Text] [Related]
2. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
Gellermann J, Ehrich JH, Querfeld U.
Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
[Abstract] [Full Text] [Related]
3. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P.
Pediatr Nephrol; 2005 Apr; 20(4):482-5. PubMed ID: 15719253
[Abstract] [Full Text] [Related]
4. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
[Abstract] [Full Text] [Related]
5. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
Pediatr Nephrol; 2005 Jul; 20(7):914-9. PubMed ID: 15891923
[Abstract] [Full Text] [Related]
6. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K.
Pediatr Nephrol; 2007 Jan; 22(1):71-6. PubMed ID: 17086405
[Abstract] [Full Text] [Related]
7. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[Abstract] [Full Text] [Related]
8. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K.
Eur J Pediatr; 2013 Apr; 172(4):513-8. PubMed ID: 23271494
[Abstract] [Full Text] [Related]
9. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A, Hari P, Moudgil A, Jordan SC.
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[Abstract] [Full Text] [Related]
10. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.
Moudgil A, Bagga A, Jordan SC.
Pediatr Nephrol; 2005 Oct; 20(10):1376-81. PubMed ID: 15977023
[Abstract] [Full Text] [Related]
11. New treatment strategies in idiopathic nephrotic syndrome.
Ulinski T, Aoun B.
Minerva Pediatr; 2012 Apr; 64(2):135-43. PubMed ID: 22495188
[Abstract] [Full Text] [Related]
12. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
13. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M.
Pediatr Nephrol; 2019 Nov; 34(11):2417-2421. PubMed ID: 31435725
[Abstract] [Full Text] [Related]
14. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children.
Nickavar A, Safarzadeh AE, Sotoudeh K, Otukesh H, Hooman N.
Iran J Kidney Dis; 2012 Sep; 6(5):346-9. PubMed ID: 22976259
[Abstract] [Full Text] [Related]
15. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
[Abstract] [Full Text] [Related]
16. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
Pediatr Int; 2015 Jan; 57(1):85-91. PubMed ID: 25225083
[Abstract] [Full Text] [Related]
17. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM.
Cochrane Database Syst Rev; 2020 Apr 16; 4(4):CD002290. PubMed ID: 32297308
[Abstract] [Full Text] [Related]
18. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
Clin Ther; 2009 Apr 16; 31(4):741-50. PubMed ID: 19446147
[Abstract] [Full Text] [Related]
19. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
Zhonghua Er Ke Za Zhi; 2014 Mar 16; 52(3):194-200. PubMed ID: 24824389
[Abstract] [Full Text] [Related]
20. Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.
Drube J, Geerlings C, Taylor R, Mengel M, Ehrich JH.
Pediatr Nephrol; 2007 Apr 16; 22(4):600-2. PubMed ID: 17235550
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
